Home/Filings/4/0001140361-23-029891
4//SEC Filing

Baker Eleanor F. 4

Accession 0001140361-23-029891

CIK 0001038133other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 6:27 PM ET

Size

28.2 KB

Accession

0001140361-23-029891

Insider Transaction Report

Form 4
Period: 2022-02-28
Baker Eleanor F.
EVP, Managing Dir. & COO, scil
Transactions
  • Award

    Common Stock

    2023-06-13+16,75725,226 total
  • Disposition to Issuer

    Performance Shares

    2023-06-137500 total
    Exp: 2025-03-31Common Stock (750 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-1335,0000 total
    Exercise: $60.94Exp: 2030-04-15Common Stock (35,000 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-1310 total
    Exercise: $60.94Exp: 2030-04-15Common Stock (1 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-132,7100 total
    Exercise: $71.84Exp: 2029-09-23Common Stock (2,710 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-131,5000 total
    Exercise: $98.95Exp: 2028-10-23Common Stock (1,500 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-139,2900 total
    Exercise: $71.84Exp: 2029-09-23Common Stock (9,290 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-139,9990 total
    Exercise: $60.94Exp: 2030-04-15Common Stock (9,999 underlying)
  • Award

    Common Stock

    2023-06-13+4,05629,282 total
  • Disposition to Issuer

    Common Stock

    2023-06-13$120.00/sh29,282$3,513,8400 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-02-28+12,50012,500 total
    Exercise: $60.94From: 2022-02-28Exp: 2030-04-15Common Stock (12,500 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2023-06-13+22,50035,000 total
    Exercise: $60.94From: 2023-06-13Exp: 2030-04-15Common Stock (22,500 underlying)
Footnotes (12)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
  • [F10]These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.
  • [F11]These stock options of the Issuer vested monthly in equal installments over four years through October 24, 2022.
  • [F12]These stock options of the Issuer vested in three equal installments on September 24, 2020, September 24, 2021 and September 24, 2022.
  • [F2]Includes 305 shares of common stock of the Issuer purchased under the Issuer's employee stock purchase plan on May 26, 2023.
  • [F3]Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.
  • [F4]Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
  • [F5]Pursuant to the Merger Agreement, these performance shares of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger and canceled in the merger in exchange for an amount in cash equal to $120.00 per share.
  • [F6]1,500 performance shares previously vested and settled.
  • [F7]Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.
  • [F8]Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
  • [F9]Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.

Documents

1 file

Issuer

HESKA CORP

CIK 0001038133

Entity typeother

Related Parties

1
  • filerCIK 0001810122

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:27 PM ET
Size
28.2 KB